Acute Porphyria Drug Database

Monograph

A10BD11 - Metformin and Linagliptin
Propably not porphyrinogenic
PNP

Rationale
Combination of two substances classified as NP (metformin) and PNP (linagliptin). For more extensive monographs, please search the individual substances metformin (ATC A10BA02) and linagliptin (ATC A10BH05) in this database.
Chemical description
Metformin is a biguanide antidiabetic. Linagliptin is a dipeptidyl peptidase-4 inhibitor.

Similar drugs
Explore alternative drugs in similar therapeutic classes A10B / A10BD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Jentadueto · Jentadueto 2,5 mg/1000 mg filmomhulde tabletten · Jentadueto 2,5 mg/850 mg filmomhulde tabletten
Belgium
Jentadueto · Jentadueto 2.5 mg - 1 000 mg compr. pellic. · Jentadueto 2.5 mg - 850 mg compr. pellic.
United Kingdom
Jentadueto · Jentadueto 2.5mg/1000mg tablets · Jentadueto 2.5mg/850mg tablets
Denmark
Jentadueto
Norway
Jentadueto
Poland
Jentadueto
Luxembourg
Jentadueto · Jentadueto-2,5/1000 · Jentadueto-2,5/850
Iceland
Jentadueto
Finland
Jentadueto · Linagliptin/Metformin Sandoz
Latvia
Autnami · Jentadueto · Linagliptin / Metformin · Linagliptin/Metformin Stada
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙